Minia University

Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo

No phase, Completed, 2025, 67 people, 15 Apr 2026, clinicaltrials.gov

NCT07288307

Phase 2, Not yet recruiting, 2026, 42 people, 17 Dec 2025, clinicaltrials.gov

NCT07068230

Phase 4, Completed, 2018, 150 people, 16 Jul 2025, clinicaltrials.gov

NCT06728982

Phase 2/3, Completed, 2024, 85 people, 11 Dec 2024, clinicaltrials.gov

NCT06553157

Phase 1/2, Completed, 2024, 56 people, 14 Aug 2024, clinicaltrials.gov

NCT06164535

Collaborator, Phase 4, Status unknown, 2023, 105 people, 11 Dec 2023, clinicaltrials.gov

NCT06038968

Early phase 1, Completed, 2022, 60 people, 15 Sept 2023, clinicaltrials.gov

NCT05946122

Phase 1, Status unknown, 2023, 106 people, 14 Jul 2023, clinicaltrials.gov

NCT05680584

Phase 1, Status unknown, 2023, 78 people, 11 Jan 2023, clinicaltrials.gov

NCT04916093

Collaborator, Phase 4, Completed, 2019, 60 people, 7 Jun 2021, clinicaltrials.gov

NCT04657809

Collaborator, Phase 2, Completed, 2020, 40 people, 8 Dec 2020, clinicaltrials.gov

NCT04426487

Early phase 1, Status unknown, 2020, 200 people, 11 Jun 2020, clinicaltrials.gov

NCT03290495

Phase 4, Completed, 2017, 30 people, 25 Sept 2017, clinicaltrials.gov

NCT01841411

Phase 4, Status unknown, 2013, 90 people, 26 Apr 2013, clinicaltrials.gov